NCT00802126View on ClinicalTrials.gov

Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

May 31, 2009

Conditions
Myopia
Interventions
DRUG

"Combination therapy IVB + rf-PDT"

low-fluence photodynamic therapy combined with intravitreal bevacizumab

Trial Locations (1)

80100

Ophthalmology Department SUN, Napoli

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT00802126 - Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy | Biotech Hunter | Biotech Hunter